# Recurrent Herpes Labialis:  Developing Drugs for Treatment and Prevention - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/recurrent-herpes-labialis-developing-drugs-for-treatment-and-prevention/e4e0fd38-d19b-43b7-9f6b-13b91c093857

> FDA guidance document: Recurrent Herpes Labialis:  Developing Drugs for Treatment and Prevention. Issue date: November 08, 2017. Get complete insights and analysis.

---

## Details

- Title: Recurrent Herpes Labialis:  Developing Drugs for Treatment and Prevention
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2017-11-08
- Last Changed: 2020-04-17
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2016-D-1504">FDA-2016-D-1504</a>

## Related Documents

- [Allergic Rhinitis: Developing Drug Products for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/allergic-rhinitis-developing-drug-products-for-treatment-guidance-for-industry/dcca7128-d84a-436f-83a2-e705904c701f)
- [Nonallergic Rhinitis:  Developing Drug Products for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/nonallergic-rhinitis-developing-drug-products-for-treatment/5453a88f-6b6b-4771-8248-e324727993ad)
- [Migraine: Developing Drugs for Acute Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/migraine-developing-drugs-for-acute-treatment/39ba4b4b-6c93-4849-a087-866c6bf4edff)